BDBM50082927 CHEMBL344117::[6-(4-Carbamimidoyl-benzyloxy)-1-oxo-1,2,3,4-tetrahydro-naphthalen-2-yl]-acetic acid
SMILES: NC(=N)c1ccc(COc2ccc3C(=O)C(CC(O)=O)CCc3c2)cc1
InChI Key: InChIKey=NKRWILYYDJVOHQ-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50082927 (CHEMBL344117 | [6-(4-Carbamimidoyl-benzyloxy)-1-ox...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Eli Lilly and Company Curated by ChEMBL | Assay Description Inhibition of fibrinogen binding to purified human alpha IIb beta3 integrin (GP IIb-IIIa) | J Med Chem 42: 4875-89 (1999) BindingDB Entry DOI: 10.7270/Q2NC60DZ | |||||||||||
More data for this Ligand-Target Pair |